These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15487557)
1. CMS posts comparison prices for popular drug classes. Med Health; 2004 Sep; 58(34):1-2. PubMed ID: 15487557 [No Abstract] [Full Text] [Related]
2. Saving money on prescription drugs. Meadows M FDA Consum; 2005; 39(5):18-26. PubMed ID: 16419288 [No Abstract] [Full Text] [Related]
3. Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs. Liu P; Dhruva SS; Shah ND; Ross JS Ann Intern Med; 2018 Dec; 169(11):817-819. PubMed ID: 30039170 [No Abstract] [Full Text] [Related]
4. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing. Bazalo G; Weiss RC Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986 [TBL] [Abstract][Full Text] [Related]
5. Summaries for patients. Potential savings with substitution of generic drugs for brand-name drugs. Ann Intern Med; 2005 Jun; 142(11):I30. PubMed ID: 15941691 [No Abstract] [Full Text] [Related]
6. Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending. Kesselheim AS; Fischer MA; Avorn J Health Aff (Millwood); 2006; 25(6):1637-47. PubMed ID: 17102189 [TBL] [Abstract][Full Text] [Related]
7. Pharmaceuticals and medical devices: Medicare Part D. ; Steiner DJ Issue Brief Health Policy Track Serv; 2014 Dec; ():1-31. PubMed ID: 25771554 [No Abstract] [Full Text] [Related]
8. Perspectives. CMS and Wall Street report... Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066 [No Abstract] [Full Text] [Related]
9. CMS retreats on Part D rule intended to reduce drug costs and improve access. Dickson V Mod Healthc; 2014 Mar; 44(11):10. PubMed ID: 24830094 [No Abstract] [Full Text] [Related]
10. Medicare prescription plan, threat to AWP could impact the ESRD drug market. Neumann ME Nephrol News Issues; 2003 Jan; 17(2):16-7, 21. PubMed ID: 12629823 [No Abstract] [Full Text] [Related]
11. A prescription for a modern Medicare program. Bach PB; McClellan MB N Engl J Med; 2005 Dec; 353(26):2733-5. PubMed ID: 16382056 [No Abstract] [Full Text] [Related]
13. Increasing generic drug use in Medicare Part D: the role of government. Kohl H; Shrank WH J Am Geriatr Soc; 2007 Jul; 55(7):1106-9. PubMed ID: 17608887 [No Abstract] [Full Text] [Related]
15. A few specialty drug prices fall--all generics. Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766 [No Abstract] [Full Text] [Related]
16. To cut costs, risky drug use. Consum Rep; 2011 Nov; 76(11):9. PubMed ID: 22022754 [No Abstract] [Full Text] [Related]
17. $4 generics: How low, how broad, and why patient engagement is priceless. Rucker NL J Am Pharm Assoc (2003); 2010; 50(6):761-3. PubMed ID: 21071325 [No Abstract] [Full Text] [Related]
18. Comparison of drug regimen costs between the Medicare prescription discount program and other purchasing systems. Hayes JM; Walczak H; Prochazka A JAMA; 2005 Jul; 294(4):427-8. PubMed ID: 16046648 [No Abstract] [Full Text] [Related]
19. Prescription drug benefits and health status among Medicare patients. Moldawsky R JAMA; 2003 Oct; 290(15):1994; author reply 1994-5. PubMed ID: 14559949 [No Abstract] [Full Text] [Related]
20. Medicare cards: no match for online prices. Consum Rep; 2004 Aug; 69(8):8. PubMed ID: 15243990 [No Abstract] [Full Text] [Related] [Next] [New Search]